GE to supply sequencing technology for breast cancer research

09/29/2013 | Genetic Engineering & Biotechnology News

Researchers at Karolinska Institutet in Europe will use GE Healthcare's sequencing technology to detect alleles and mutations linked to metastatic breast cancer. The deal, whose terms were not disclosed, is part of GE's initiative to invest in the development of novel molecular imaging and cancer diagnostic capabilities. The company is also investing in biopharmaceutical manufacturing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC